Kinome Profiling Reveals Abnormal Activity of Kinases in Skeletal Muscle From Adults With Obesity and Insulin Resistance
- 26 December 2019
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 105 (3) , 644-659
Abstract
Context: Obesity-related insulin resistance (OIR) is one of the main contributors to type 2 diabetes and other metabolic diseases. Protein kinases are implicated in insulin signaling and glucose metabolism. Molecular mechanisms underlying OIR involving global kinase activities remain incompletely understood. Objective: To investigate abnormal kinase activity associated with OIR in human skeletal muscle. Design: Utilization of stable isotopic labeling-based quantitative proteomics combined with affinity-based active enzyme probes to profile in vivo kinase activity in skeletal muscle from lean control (Lean) and OIR participants. Participants: A total of 16 nondiabetic adults, 8 Lean and 8 with OIR, underwent hyperinsulinemic-euglycemic clamp with muscle biopsy. Results: We identified the first active kinome, comprising 54 active protein kinases, in human skeletal muscle. The activities of 23 kinases were different in OIR muscle compared with Lean muscle (11 hyper- and 12 hypo-active), while their protein abundance was the same between the 2 groups. The activities of multiple kinases involved in adenosine monophosphate–activated protein kinase (AMPK) and p38 signaling were lower in OIR compared with Lean. On the contrary, multiple kinases in the c-Jun N-terminal kinase (JNK) signaling pathway exhibited higher activity in OIR vs Lean. The kinase-substrate–prediction based on experimental data further confirmed a potential downregulation of insulin signaling (eg, inhibited phosphorylation of insulin receptor substrate-1 and AKT1/2). Conclusions: These findings provide a global view of the kinome activity in OIR and Lean muscle, pinpoint novel specific impairment in kinase activities in signaling pathways important for skeletal muscle insulin resistance, and may provide potential drug targets (ie, abnormal kinase activities) to prevent and/or reverse skeletal muscle insulin resistance in humans.Keywords
Funding Information
- NIH (R01DK081750, R01DK107666)
- NIDDK (R01DK081750)
- National Eye Institute (R01EY022230, 101 BX002801-01)
This publication has 72 references indexed in Scilit:
- Sugars, obesity, and cardiovascular disease: results from recent randomized control trialsEuropean Journal of Nutrition, 2016
- Overweight, obesity and risk of all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus: a dose–response meta-analysis of prospective cohort studiesEuropean Journal of Epidemiology, 2014
- In vivo activation of the PI3K–Akt pathway in mouse beta cells by the EGFR mutation L858R protects against diabetesDiabetologia, 2014
- p38 Mitogen-Activated Protein Kinase: A Critical Node Linking Insulin Resistance and Cardiovascular Diseases in Type 2 Diabetes MellitusEndocrine, Metabolic & Immune Disorders - Drug Targets, 2009
- The AMP-regulated kinase family: Enigmatic targets for diabetes therapyMolecular and Cellular Endocrinology, 2009
- c-Jun N-terminal kinase pathways in diabetesThe International Journal of Biochemistry & Cell Biology, 2008
- The Protein Kinase Complement of the Human GenomeScience, 2002
- Increased protein kinase C theta in skeletal muscle of diabetic patientsMetabolism, 2001
- Insulin action and insulin resistance in human skeletal muscleDiabetologia, 2000
- Insulin Action, Diabetogenes, and the Cause of Type II DiabetesDiabetes, 1994